Search Orphan Drug Designations and Approvals
-
Generic Name: | reboxetine |
---|---|
Date Designated: | 10/15/2018 |
Orphan Designation: | Treatment of narcolepsy |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Axsome Therapeutics, Inc. 25 Broadway, 9th Floor Suite 2000 New York, New York 10004 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-